Literature DB >> 1700866

Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation.

S Nishibe1, M I Wahl, S M Hernández-Sotomayor, N K Tonks, S G Rhee, G Carpenter.   

Abstract

Phospholipase C-gamma 1 (PLC-gamma 1), an isozyme of the phosphoinositide-specific phospholipase C family, which occupies a central role in hormonal signal transduction pathways, is an excellent substrate for the epidermal growth factor (EGF) receptor tyrosine kinase. Epidermal growth factor elicits tyrosine phosphorylation of PLC-gamma 1 and phosphatidylinositol 4,5-bisphosphate hydrolysis in various cell lines. The ability of tyrosine phosphorylation to activate the catalytic activity of PLC-gamma 1 was tested. Tyrosine phosphorylation in intact cells or in vitro increased the catalytic activity of PLC-gamma 1. Also, treatment of EGF-activated PLC-gamma 1 with a tyrosine-specific phosphatase substantially decreased the catalytic activity of PLC-gamma 1. These results suggest that the EGF-stimulated formation of inositol 1,4,5-trisphosphate and diacylglycerol in intact cells results, at least in part, from catalytic activation of PLC-gamma 1 through tyrosine phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700866     DOI: 10.1126/science.1700866

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  161 in total

1.  Regulation of mouse skeletal muscle L-type Ca2+ channel by activation of the insulin-like growth factor-1 receptor.

Authors:  O Delbono; M Renganathan; M L Messi
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase.

Authors:  M Hegen; J Kameoka; R P Dong; S F Schlossman; C Morimoto
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

3.  Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.

Authors:  B J Mayer; P K Jackson; R A Van Etten; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

Review 4.  Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors.

Authors:  S Cockcroft; G M Thomas
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

5.  Specific changes of Ras GTPase-activating protein (GAP) and a GAP-associated p62 protein during calcium-induced keratinocyte differentiation.

Authors:  E Filvaroff; E Calautti; F McCormick; G P Dotto
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

6.  Pentosan polysulfate, a potent anti HIV and anti tumor agent, inhibits protein serine/threonine and tyrosine kinases.

Authors:  A K Srivastava; R P Sékaly; J L Chiasson
Journal:  Mol Cell Biochem       Date:  1993-03-24       Impact factor: 3.396

7.  Activation of phospholipase A2 and stimulation of prostaglandin E2 production by transforming growth factor-alpha in rat thymic epithelial cells requires influx of calcium.

Authors:  P Liu; M Wen; L Sun; J Hayashi
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

8.  Mechanism of inhibition of IgE-dependent histamine release from rat mast cells by xestobergsterol A from the Okinawan marine sponge Xestospongia bergquistia.

Authors:  M Takei; A Umeyama; N Shoji; S Arihara; K Endo
Journal:  Experientia       Date:  1993-02-15

9.  A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains.

Authors:  S Ahmad; D Banville; Z Zhao; E H Fischer; S H Shen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

10.  Epitope-tagged Gq alpha subunits: expression of GTPase-deficient alpha subunits persistently stimulates phosphatidylinositol-specific phospholipase C but not mitogen-activated protein kinase activity regulated by the M1 muscarinic acetylcholine receptor.

Authors:  N X Qian; S Winitz; G L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.